Dr Reddy launches triple drug combination for diabetes

Hyderabad, July 10 (UNI) Dr Reddy's Laboratories has launched a drug combination ideal for treating triple defects in diabetes.

A company release here said TM (Glimepiride+ Metformin+ Pioglitazone), launched nationwide on July seven, marks the entry of Dr Reddy's in the triple drug combination oral hypoglycemic agents market.

Glimy MP TM was an extension of the existing products of Dr Reddy's used in the management of Type two diabetes, the release added.

UNI